Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment for

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Acute Ischemic Stroke
Interventions
DRUG

intra-arterial infusion albumin

The experimental group would inject 20% human blood albumin solution into the responsible blood vessel supply area by catheter artery at a dose of 0.6g/kg. The infusion time is 20-30 minutes. All participant will receive mechanical thrombectomy and a standard clinical therapy.

OTHER

mechanical thrombectomy and a standard clinical therapy

mechanical thrombectomy and a standard clinical therapy

Trial Locations (1)

300222

Ming wei, Tianjin, China

All Listed Sponsors
lead

Tianjin Huanhu Hospital

OTHER

NCT06172387 - Intra-arterial Albumin in Acute Ischemic Stroke After Endovascular Treatment for | Biotech Hunter | Biotech Hunter